Director, Temple Lung Center
Dr. Criner is an internationally renowned pulmonologist who specializes in Pulmonary Disease, with a special focus on Chronic Obstructive Lung Disease (COPD), Transplant Medicine-Lung and Airway Disorders.
Related Videos
Video
Lung Transplantation for COPD Patients
Chronic Obstructive Pulmonary Disease (COPD) is the sixth leading cause of death in the U.S., affecting nearly 16 million adults. Dr. Gerard Criner, Director of the Temple Lung Center, recently joined the Global Forum on Lung Transplantation ...
Video
Bronchoscopic Lung Volume Reduction in Patients with Advanced Emphysema
As part of the Pulmonology On Air 2022 Global Event, Gerard Criner, MD, FACP, FACCP, Director of the Temple Lung Center, demonstrates a LIVE endobronchial valve placement on a patient with advanced homogenous emphysema.
Video
Lung Cancer Screening and SPN in the Patient with COPD
Patients with advanced Chronic Obstructive Pulmonary Disease (COPD) are at increased risk of lung cancer, and should be screened with low-dose CT.
Video
In this podcast recorded by the American Association of Bronchology and Interventional Pulmonology, Gerard J. Criner, MD discusses patient selection for Bronchoscopic Lung Volume Reduction.
Video
Gerard J. Criner, MD, FACP, FACCP, discusses the AIRFLOW-3 study which evaluates the efficacy of targeted lung denervation for patients with COPD.
Video
Gala Therapuetics RheSolve Study Treating Patients with Chronic Bronchitis
Gerard J. Criner, MD, FACP, FACCP, outlines the details of the Gala Therapeutics RheSolve Study for treating patients with chronic bronchitis.
Video
Bronchoscopic Lung Volume Reduction Procedural Tips and Tricks
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States. Despite optimal pharmacological treatment, many patients with chronic obstructive pulmonary disease remain very disabled.
Video
Metered dose Nitrogen Cryospray for Treatment of Chronic Bronchitis in Patients with COPD (SPRAY-CB)
Gerard Criner, MD, FACP, FACCP, outlines the details of the SPRAY-BC clinical trial for the treatment of chronic bronchitis in patients with COPD.
